When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis

Genetic Epidemiology

Volumn 35, Issue 6, 2011, Pages 568-571

  Gourraud, Pierre Antoine ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bioequivalence; KIF1B; Multiple sclerosis; Negative results

Indexed keywords

KINESIN; KINESIN FAMILY MEMBER 1B; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MULTIPLE SCLEROSIS; PEDIGREE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; COHORT STUDIES; FALSE POSITIVE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; KINESIN; MODELS, GENETIC; MODELS, STATISTICAL; MOLECULAR EPIDEMIOLOGY; MULTIPLE SCLEROSIS; RESEARCH DESIGN; RISK;

EID: 80051826776     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20592     Document Type: Article

References (7)

1. Altman DG, Bland JM. 1995. Absence of evidence is not evidence of absence. BMJ 311:485.
2. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J, Link J, Lundstrom W, Greiner E, Dessa Sadovnick A, Goossens D, Van Broeckhoven C, Del-Favero J, Ebers G, Oostra BA, van Duijn C, Hintzen R. 2008. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 40:1402-1403.
3. Barker L, Rolka H, Rolka D, Brown C. 2001. Equivalence testing for binomial random variables. Am Stat 55:279-287.
4. IMSGC, Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, et al. 2010. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet 42:469-470; author reply 470-471.
5. Lyons DA, Naylor SG, Scholze A, Talbot WS. 2009. Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat Genet 41:854-858.
6. Martinelli-Boneschi F, Esposito F, Scalabrini D, Fenoglio C, Rodegher ME, Brambilla P, Colombo B, Ghezzi A, Capra R, Collimedaglia L, et al. 2010. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort. Eur J Neurol 17:740-745.
7. Schuirmann DJ. 1987. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15:657-680.